Skip to content
DilutionScan
Retension Pharmaceuticals, Inc. logo
RTSN$11.46-6.60%

Retension Pharmaceuticals, Inc.

Sector: Pharmaceutical PreparationsIndustry: Medical - PharmaceuticalsCountry: USExchange: Nasdaq

Mkt Cap & EV$95.49M /
Float & O/S3.72M / 8.33M
Est. Net Cash/Sh
Inst OwnNot measured

DilutionScan read 22 of Retension Pharmaceuticals, Inc.'s SEC filings and found 3 warrant series, 2 convertibles, 1 S-1 registration and 1 completed offering on file for RTSN. The latest dilution event on file is an offering on Oct 13, 2026. Analysis updated Nov 13, 2026.

Signal8 Summary

Raise routes on file: no active ATM, effective shelf, issuer S-1 or active equity line in the filings read · latest dilution event 35 days ago

Overall Risk
Offering Ability
Overhead Supply
Historical
Cash Need

AI dilution summary

The dominant contractual driver and its mechanism, then each further driver ranked.

Latest dilution event

Oct 13, 2026 · Offering

How we read filings

Every warrant, convertible, ATM and shelf, cited to the filing

A free account reads 3 tickers a day in full

Get Pro · every ticker

From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)

Share count and cash history

Shares outstanding, potential dilution and cash over time

S-1 · 1

What is this?

Size, shares registered and dates with Pro

S-1 · primary offering

Issued 2026

Completed

Proposed maximum

Shares registered

Filed
Effective
Filing link and full terms

Warrants · 3

What is this?

Exercise price, shares and dates with Pro

Warrant

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Warrant

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Warrant

Outstanding

Shares Underlying

Exercise Price

Outstanding
Type
Anti-Dilution
Cashless Exercise
Expiration
Filing link and full terms

Convertibles · 2

What is this?

Principal, conversion terms and dates with Pro

Series A Convertible Preferred Stock

Converted

Principal

Conversion Price

Remaining principal
Shares on conversion
Interest rate
Maturity
Filing link and full terms

Series B Convertible Preferred Stock

Converted

Principal

Conversion Price

Remaining principal
Shares on conversion
Interest rate
Maturity
Filing link and full terms

Offerings · 1

What is this?

Proceeds, price, shares and agent with Pro

Public offering

Issued 2026

Gross proceeds

Price per share

Shares issued
Warrant coverage
Placement agent
Filing link and full terms

Know who's about to sell into your RTSN trade

Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.

Get Pro · every ticker

From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)

DilutionScanEvery instrument in full · From $29.99/mo